So, repotrectinib is a treatment specifically for certain types of lung cancer that have ROS1 or NTRK-fusion in them. It’s one of those TRK/ROS1/ALK inhibitors, which are all about stopping these specific proteins (kinases) that are helping cancer cells grow. You can get repotrectinib in these 40 mg caps.
Typically, you start with a high dose of 160 mg a day for two weeks, then after that, you take just 160 mg two times a day. It comes in bottles with 60 caps in each.
